{"id":"W4412925033","doi":"10.3389/fonc.2025.1605282","title":"Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study","year":2025,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Cabozantinib; Nivolumab; Medicine; Renal cell carcinoma; Oncology; Internal medicine; Performance status; Kidney cancer; Progression-free survival; Cohort; Urology; Overall survival; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007373299,0.0002522836,0.0007596193,0.000548457,0.00005810324,0.0000236428,0.0005013214,0.00009203466,0.0001119532],"category_scores_gemma":[0.0002510501,0.0001910091,0.000110109,0.000661794,0.0001538158,0.00009374585,0.0002268061,0.0005672447,0.00002010396],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002895351,"about_ca_system_score_gemma":0.001266187,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01651673,"about_ca_topic_score_gemma":0.02124888,"domain_scores_codex":[0.9974487,0.000497253,0.0006876555,0.000605063,0.0003736056,0.0003876514],"domain_scores_gemma":[0.9982716,0.0008180466,0.0001745021,0.0005755817,0.00008224092,0.00007800125],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001677252,0.0009450679,0.9489363,0.0000218462,0.0001653229,0.001788328,0.002660381,0.0001301422,0.0003172915,0.0000239962,0.03897008,0.004364023],"study_design_scores_gemma":[0.010121,0.0009373913,0.9727368,0.0001762976,0.0003528304,0.00001121343,0.005864244,0.001768622,0.0009429182,0.0003181774,0.006611396,0.0001591258],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9723096,0.002777788,0.0003858226,0.004165196,0.002284114,0.001479638,0.00001412894,0.00002474235,0.0165589],"genre_scores_gemma":[0.98728,0.0002019136,0.005744768,0.0005627015,0.0001327143,0.0002516851,0.00003814157,0.0000197113,0.005768399],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03235868,"threshold_uncertainty_score":0.9966108,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0394263623607299,"score_gpt":0.3353229784516191,"score_spread":0.2958966160908892,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}